Scott Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals. He was also President, and CEO of Nycomed Salutar, a company that makes biopharmaceuticals. He has lead the research and development of three FDA-approved drugs: Omniscan, Teslascan, and Cubicin. Dr. Scott Rocklage has over thirty years of management experience within the healthcare industry. Dr.